Legend: : Special Mention  : Important : Very Important : Key Development |
| |
| |
DNA immunization with Na+-K+ ATPase (Sseat-6) induces protective immunity to larval Strongyloides stercoralis in mice.
LA Kerepesi, PB Keiser, TJ Nolan, GA Schad, D Abraham, TB Nutman, Infect Immun. 2005 Apr:2298-305 |
| |
Association of a sex-related difference of Strongyloides stercoralis-specific IgG4 antibody titer with the efficacy of treatment of strongyloidiasis.
M Satoh, H Toma, S Kiyuna, Y Shiroma, A Kokaze, Y Sato, Am J Trop Med Hyg. 2004 Jul:107-11 |
| |
Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
EM Carvalho, A Da Fonseca Porto, Parasite Immunol. 2004 Nov-Dec:487-97 |
| |
Intestinal damage in strongyloidiasis: the imbalance between cell death and proliferation.
AL Werneck-Silva, EP Alvares, P Gama, AO Damião, LH Osaki, D Ogias, AM Sipahi, Dig Dis Sci. 2006 Jun:1063-9 |
| Supplementary evidence: |
| |
An in vitro larval motility assay to determine anthelmintic sensitivity for human hookworm and Strongyloides species.
AC Kotze, S Clifford, J O'Grady, JM Behnke, JS McCarthy, Am J Trop Med Hyg. 2004 Nov:608-16 |
| |
Comparison of anthelmintic effects of two doses of ivermectin on intestinal strongyloidiasis in patients negative or positive for anti-HTLV-1 antibody.
O Zaha, T Hirata, N Uchima, F Kinjo, A Saito, J Infect Chemother. 2004 Dec:348-51 |
| |
Comparison of enzyme-linked immunosorbent assay and indirect immunofluorescence assay in the diagnosis of human strongyloidiasis.
S Koosha, M Fesharaki, MB Rokni, Indian J Gastroenterol. 2004 Nov-Dec:214-6 |
| |
Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management.
S Lim, K Katz, S Krajden, M Fuksa, JS Keystone, KC Kain, CMAJ. 2004 Aug 31:479-84 |
| |
Displaced bacterial colonies indicating Strongyloides larval migration on agar plates.
MR Mariappan, O Vielemeyer, O Fadare, S Paventy, FJ Bia, Arch Pathol Lab Med. 2004 Jun:711-2 |
| |
Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda.
M Brown, M Kizza, C Watera, MA Quigley, S Rowland, P Hughes, JA Whitworth, AM Elliott, J Infect Dis. 2004 Nov 15:1869-79 |
| |
Helminthic infection down-regulates type 1 immune responses in human T cell lymphotropic virus type 1 (HTLV-1) carriers and is more prevalent in HTLV-1 carriers than in patients with HTLV-1-associated
AF Porto, SB Santos, AL Muniz, V Basilio, W Rodrigues Jr, FA Neva, WO Dutra, KJ Gollob, S Jacobson, EM Carvalho, J Infect Dis. 2005 Feb 15:612-8 |
| |
Soil-transmitted helminthiases and health behaviors among schoolchildren and community members in a west-central border area of Thailand.
MT Anantaphruti, J Waikagul, W Maipanich, S Nuamtanong, S Pubampen, Southeast Asian J Trop Med Public Health. 2004 Jun:260-6 |
| |
Strongyloides hyperinfection syndrome after heart transplantation: case report and review of the literature.
MW Schaeffer, JF Buell, M Gupta, GD Conway, SA Akhter, LE Wagoner, J Heart Lung Transplant. 2004 Jul:905-11 |
| |
Strongyloides stercoralis in the Immunocompromised Population.
PB Keiser, TB Nutman, Clin Microbiol Rev. 2004 Jan:208-17 |
| |
Strongyloides stercoralis infection as a manifestation of immune restoration syndrome.
AC Kim, HC Lupatkin, Clin Infect Dis. 2004 Aug 1:439-40 |
| |
Strongyloidiasis in children five years and below.
HO Dada-Adegbola, RA Bakare, West Afr J Med. 2004 Jul-Sep:194-7 |
| |
Strongyloidiasis.
K Asano, S Tada, T Kamio, T Matsumoto, H Suko, M Iida, Gastrointest Endosc. 2004 Oct:606-7 |
| |
Successful ivermectin treatment of hepatic strongyloidiasis presenting with severe eosinophilia.
Z Gulbas, M Kebapci, O Pasaoglu, E Vardareli, South Med J. 2004 Sep:907-10 |
| |
The amphidial neuron pair ALD controls the temperature-sensitive choice of alternative developmental pathways in the parasitic nematode, Strongyloides stercoralis.
TJ Nolan, M Brenes, FT Ashton, X Zhu, WM Forbes, R Boston, GA Schad, Parasitology. 2004 Dec:753-9 |
| |
The cost-effectiveness of ivermectin vs. albendazole in the presumptive treatment of strongyloidiasis in immigrants to the United States.
P Muennig, D Pallin, C Challah, K Khan, Epidemiol Infect. 2004 Dec:1055-63 |
| |
The spectrum of GI strongyloidiasis: an endoscopic-pathologic study.
BF Thompson, LC Fry, CD Wells, M Olmos, DH Lee, AJ Lazenby, KE M&oeig;nkemuller, Gastrointest Endosc. 2004 Jun:906-10 |
| |
Treatment strategies in controlling strongyloidiasis.
M Satoh, A Kokaze, Expert Opin Pharmacother. 2004 Nov:2293-301 |
| |
Why does HIV infection not lead to disseminated strongyloidiasis?
ME Viney, M Brown, NE Omoding, JW Bailey, MP Gardner, E Roberts, D Morgan, AM Elliott, JA Whitworth, J Infect Dis. 2004 Dec 15:2175-80 |